Soleus Capital Management, L.P. 4 D Molecular Therapeutics, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.22 Billion
- Q1 2024
A detailed history of Soleus Capital Management, L.P. transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 197,098 shares of FDMT stock, worth $4.06 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
197,098
Previous 45,748
330.83%
Holding current value
$4.06 Million
Previous $926,000
578.08%
% of portfolio
0.51%
Previous 0.12%
Shares
10 transactions
Others Institutions Holding FDMT
# of Institutions
157Shares Held
50.3MCall Options Held
718KPut Options Held
370K-
Vr Adviser, LLC New York, NY4.4MShares$90.6 Million12.03% of portfolio
-
Black Rock Inc. New York, NY4.28MShares$88.2 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.92MShares$80.7 Million3.74% of portfolio
-
Janus Henderson Group PLC London, X03.2MShares$65.8 Million0.06% of portfolio
-
Goldman Sachs Group Inc New York, NY3.06MShares$62.9 Million0.02% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $666M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...